← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
CGTBiologicstaleNingbo Cancer HospitalPhase 2

PD-1 antibody expressing mesothelin specific CAR-T cells (PD-1 antibody expressing mesothelin specific CAR-T cells)

Solid Tumor, Adult; Advanced Cancer · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
AntibodyBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

PD-1 mAb (PD-1 mAb)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
CGTBiologicstalejiuwei cuiPhase 1

PD-1-M1-NK Cells (PD-1-M1-NK Cells)

Advanced Gastric or Colorectal Cancer · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang UniversityPhase 1

PD1-PSMA-CART cells (PD1-PSMA-CART cells)

Castrate-Resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleBiocon Biologics UK LtdPhase 3

trastuzumab (Herceptin, PERT-IJS plus trastuzumab, carboplatin and docetaxel)

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
ADCBiologicstalePfizerPhase 1

PF-08046033 (PF-08046033)

Non-Small-Cell Lung; Esophageal Cancer · Non-Small-Cell Lung

#Non-Small-CellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstalePfizerPhase 1

PF-08046876 (PF-08046876)

Advanced/Metastatic Solid Tumors; Bladder Cancer · Advanced/Metastatic Solid Tumors

#AdvancedMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 1상태 RECRUITING
CGTBiologicstaleNational Cancer Institute (NCI)Phase 1

Anti-CEA TCR PBL (PG13-CEA_TCR, PG13-CEA_TCR (Anti-CEA TCR PBL))

Metastatic Cancer · CEA

#CEA#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleNational Cancer Institute (NCI)Phase 2

PG13-MAGE-A3 TCR9W11 (anti-MAGE-A3/12 TCR, PG13-MAGE-A3 TCR9W11, PG13-MAGE-A3 TCR9W11 (anti-MAGE-A3/12 TCR) Transduced Autologous Peripheral Blood Lymphocytes)

Metastatic Cancer; Metastatic Renal Cancer · Metastatic Cancer

#MetastaticCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
ADCBiologicstalePheon TherapeuticsPhase 1

PHN-010 (PHN-010)

Lung Cancer; Colon Cancer · Lung Cancer

#LungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstalePheon TherapeuticsPhase 1

PHN-012 (PHN-012)

Colon Cancer; Pancreatic Cancer · Colon Cancer

#ColonCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleNorthwestern UniversityPhase 1

PI3K inhibitor BYL719 (PI3K inhibitor BYL719)

HER2-positive Breast Cancer; Recurrent Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 4%임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 1

PIN+sintilimab (PIN+sintilimab)

Colorectal Cancer; Adult · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

PRG2505 (PRG2505)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleShanghai Changzheng HospitalPhase 1

BRL-302 (PSMA-UCAR T, PSMA-UCAR T (BRL-302))

Metastatic Prostate Cancer; Castration-resistant Prostate Cancer · PSMA

#PSMA#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 3

PTC+Pertuzumab (PTC+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
ADCBiologicstaleBorstkanker Onderzoek GroepPhase 2

PTC-Pz (PTC-Pz)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, PXS-5505 and Atezolizumab and Bevacizumab)

Hepatocellular Carcinoma; Cancer of Liver · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleSamsung Medical CenterPhase 2

atezolizumab (Tecentriq, Pabociclib, Endocrine, Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib, Atezolizumab, or ET + CDK4/6 inhibitors)

Premenopausal HR+/HER2- Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleRocheApproved

bevacizumab + oxaliplatin + capecitabine (Pabolizumab+ bevacizumab and CapeOX, Pabolizumab+ bevacizumab and CapeOX (bevacizumab + oxaliplatin + capecitabine))

Locally Advanced Colorectal Cancer · Locally Advanced Colorectal Cancer

#LocallyAdvancedColorectalCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING

57 / 75 페이지

← 이전다음 →